GR1007299B - Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου - Google Patents

Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου

Info

Publication number
GR1007299B
GR1007299B GR20100100183A GR20100100183A GR1007299B GR 1007299 B GR1007299 B GR 1007299B GR 20100100183 A GR20100100183 A GR 20100100183A GR 20100100183 A GR20100100183 A GR 20100100183A GR 1007299 B GR1007299 B GR 1007299B
Authority
GR
Greece
Prior art keywords
effervescent
tablets
original
hydrochloric metformin
metformin composition
Prior art date
Application number
GR20100100183A
Other languages
English (en)
Inventor
Ιουλια Τσετη
Original Assignee
Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, filed Critical Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε,
Priority to GR20100100183A priority Critical patent/GR1007299B/el
Publication of GR1007299B publication Critical patent/GR1007299B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μια με ιδιαίτερα χαρακτηριστικά αναβράζουσα φαρμακευτική σύνθεση με τη μορφή δισκίου, που περιέχει θεραπευτικές δόσεις Υδροχλωρικής Μετφορμίνης για στοματική χορήγηση, στη θεραπεία της υπεργλυκαιμίας. Η αναβράζουσα σύνθεση της παρούσας εφεύρεσης περιέχει εκτός των συμβατικών εκδόχων επιλεκτικά την Δισακχαρική αλκοόλη (Isomalt) και το αμινοξύ Γλυκίνη, έκδοχα που διασφαλίζουν τη σταθερότητα, την ικανοποιητικά χρονικώς αποδεκτή διαλυτοποίηση του δισκίου και την εξαίρετη γεύση του διαλύματος που προκύπτει.
GR20100100183A 2010-03-24 2010-03-24 Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου GR1007299B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20100100183A GR1007299B (el) 2010-03-24 2010-03-24 Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20100100183A GR1007299B (el) 2010-03-24 2010-03-24 Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου

Publications (1)

Publication Number Publication Date
GR1007299B true GR1007299B (el) 2011-06-06

Family

ID=44260129

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20100100183A GR1007299B (el) 2010-03-24 2010-03-24 Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου

Country Status (1)

Country Link
GR (1) GR1007299B (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013077822A1 (en) * 2011-11-23 2013-05-30 Mahmut Bilgic New formulations for treatment of diabetes

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283369A2 (fr) * 1987-03-06 1988-09-21 Lipha, Lyonnaise Industrielle Pharmaceutique Emploi de la Metformine, dans la préparation de médicaments
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen
WO2003026610A2 (en) * 2001-09-25 2003-04-03 Ranbaxy Laboratories Limited Process for the preparation of fast dissolving dosage form
US20040057995A1 (en) * 1999-07-08 2004-03-25 Marco Schroeder Process for the production of rapidly disintegrating, solid pharmaceutical preparations
US20040219212A1 (en) * 2001-05-23 2004-11-04 Catherine Castan Single-daily dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
WO2005065663A1 (en) * 2003-12-31 2005-07-21 Alpharma, Inc. Rosiglitazone and metformin formulations
WO2007038979A1 (en) * 2005-09-22 2007-04-12 Swissco Development Ag Effervescent metformin composition and tablets and granules made therefrom

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283369A2 (fr) * 1987-03-06 1988-09-21 Lipha, Lyonnaise Industrielle Pharmaceutique Emploi de la Metformine, dans la préparation de médicaments
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen
US20040057995A1 (en) * 1999-07-08 2004-03-25 Marco Schroeder Process for the production of rapidly disintegrating, solid pharmaceutical preparations
US20040219212A1 (en) * 2001-05-23 2004-11-04 Catherine Castan Single-daily dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
WO2003026610A2 (en) * 2001-09-25 2003-04-03 Ranbaxy Laboratories Limited Process for the preparation of fast dissolving dosage form
WO2005065663A1 (en) * 2003-12-31 2005-07-21 Alpharma, Inc. Rosiglitazone and metformin formulations
WO2007038979A1 (en) * 2005-09-22 2007-04-12 Swissco Development Ag Effervescent metformin composition and tablets and granules made therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BURT P J; ET AL: "The Laplacian pyramid as a compact image code" *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013077822A1 (en) * 2011-11-23 2013-05-30 Mahmut Bilgic New formulations for treatment of diabetes

Similar Documents

Publication Publication Date Title
CL2013001252A1 (es) Capsula para administracion oral que comprende n-terc-butil-3-[(5-metil-2-{[4-(2-pirrolidin-1-iletoxi)fenil]amino}pirimidin-4-il)amino]bencenosulfonamida, una celulosa microcristalina y estearil fumarato de sodio; forma de dosificacion unitaria; metodo para tratar mielofibrosis; metodo de preparacion; y articulo de preparacion.
UY33062A (es) Comprimidos y composiciones farmacéuticas comprimibles recubiertos y métodos de fabricación
WO2008146178A3 (en) A novel tablet dosage form
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
TW200744672A (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
PH12014501408A1 (en) Immediate release multi unit pellet system
WO2011104652A3 (en) Veterinary compositions
TN2015000135A1 (en) Modified release formulations for oprozomib
PH12015500653A1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
AR070392A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de eleboracion
WO2014144407A8 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
MX2015008068A (es) Unidad solida con alto contenido en fexofenadina y su procedimiento de preparacion.
MX2019014687A (es) Formulaciones farmaceuticas orales de remogliflozina.
GR1007299B (el) Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου
PH12016500119A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
MX2014005153A (es) Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
PH12016500120A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
MX2014010038A (es) Tabletas dispersables con sabor enmascarado.
WO2012080984A3 (es) Comprimido farmacéutico de liberación controlada para administración oral
IN2013MU03389A (el)
WO2013054178A8 (en) Extended release pharmaceutical compositions containing carmabazepine
UA95343C2 (ru) Лекарственный препарат амисульприда в форме таблетки и способ его приготовления
UA99317C2 (ru) Фармацевтическая композиция в форме таблеток для лечения вирусных заболеваний
MD3770G2 (ro) Metodă de profilaxie a infecţiilor respiratorii virale acute nongripale

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20110714